Αποτελέσματα Αναζήτησης
DEA is pleased to provide you with the 2023 edition of the Practitioner’s Manual to assist you in understanding the provisions of the CSA and its implementing regulations. This Practitioner’s Manual will answer questions you may encounter in your practice and provide guidance in complying with the CSA and DEA regulations.
This document is an internal Drug Enforcement Administration quality system document which provides a summary sheet for validated qualitative method (GUARDS). The document is updated periodically and is current as of March 11, 2024, and is provided for informational purposes only.
The Drug Enforcement Administration (DEA) is pleased to provide you with the 2022 edition of the Narcotic Treatment Program Manual (NTP Manual) to assist you in understanding the provisions of the Controlled Substances Act (CSA).
This guidance document addresses when a Drug Enforcement Administration (DEA)-registered reverse distributor is considered to have received a sealed inner liner from either DEA registrants authorized as collectors or Federal, State, Tribal, or local law enforcement agencies.
Drugs of Abuse, A DEA Resource Guide, is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects
Modify your existing Retail Online Pharmacy information. Allows a current DEA registrant to check the validity of another DEA registrant, and download Registrant dataset.
The Drug Enforcement Administration (DEA) was established in 1973 to serve as the primary federal agency responsible for the enforcement of the Controlled Substances Act (CSA). The CSA sets forth the federal law regarding both illicit and licit (pharmaceutical) controlled substances. With respect to pharmaceutical controlled substances, DEA’s